A revolutionary new treatment for rheumatoid arthritis. #StartActivating #SetPointSystem #SetPointTherapy Individual outcomes vary. Safety info: spm.care/ISI

Valencia, CA
Based in United States
Join us and @USSONAR_Rh Monday, October 5th at 8:30 pm ET for a webinar with Dr. Jeffrey Curtis (UAB) to discuss vagus nerve-mediated neuroimmune modulation, a novel therapy treatment for rheumatoid arthritis. Register today: spm.care/webinar
4
169
On @AmericaMedicine, Ken with @minnakohlermd shares his #SetPointTherapy story and tips for how he navigated new treatment options with his rheumatologist. A must-listen for people living with #RA👇 electracast.com/podcast/medi… Individual outcomes vary. ISI: spm.care/ISI
1
1
104
A landmark @MedEconomics study projects the #SetPointSystem could save the U.S. health system per patient over a lifetime compared to standard-of-care, with costs potentially recouped within 16 months. Read here: setpointmedical.com/publicat… Safety info: spm.care/ISI
1
77
The first #SetPointSystem procedure in California was just preformed at @DignityHealth - St. John's Regional Medical Center! Congrats to Dr. Gita Fatemi, Dr. Akinwunmi Oni-Orisan and SJRMC teams. Get the full story: dignityhealth.org/central-co… Safety Info: spm.care/ISI
1
1
167
The #SetPointSystem has arrived in Texas. We're proud to announce the first SetPoint System procedure in the state, performed by Peterson at @Ascensionorg Dell Seton Medical Center at The University of Texas. Safety info: spm.care/ISI setpointmedical.com/first-se…
1
117
We’re honored that the SetPoint System has been named one of @TIME’s Best Inventions of 2025 in Medical & Healthcare. 🏆 Read about it here: time.com/collections/best-in… Please see important safety information at spm.care/ISI #TIMEBestInventions #StartActivating #RA
2
8
2,848
We were honored to have our national surgical PI @RMarkRichardson present RESET-RA results during the Plenary Session at #AANS25. Data presented highlight SetPoint System’s potential as a first-of-its-kind neuroimmune modulation treatment for RA. #TheSetPointAdvantage
1
4
337
Today is #WorldArthritisDay, dedicated to raising awareness about the impact of arthritis in our world. 24% of U.S. adults suffer from arthritis. Advances in care & clinical effectiveness are greatly needed for these patients, and we're committed to pursuing solutions. #WAD2022
2
4
We spent our volunteer day helping beautify the @BridgeToHome shelter, build/repair furniture, paint walls & create welcoming, functional spaces for the shelter's residents. It's these kinds of days where we feel most connected to our mission, our community, and each other.
Last week, the @SetPointMed team came together for a day of community service at @BridgeToHome, a local org helping individuals and families in Santa Clarita Valley move from homelessness to housing. Learn more about their work at btohome.org.
1
Here's Dr. @RMarkRichardson, nat'l co-PI of the RESET-RA study, sharing the study design, and Dr. Frieda Koopman presenting an update on prior studies about treating #RA with #VNS. We continue to advance this promising therapy for autoimmune conditions! #Rheumatology #MedEd
1
3
7
Our Chief Medical Officer David Chernoff will be at CCR-W to discuss the ongoing RESET-RA study. Please stop by poster in the Carousel room on 9/18 to say hello and learn more about the study using vagus nerve stimulation to treat #RA. #TheSetPointAdvantage #CCRWest #CCR21
1
6
In recognition of #PainAwarenessMonth, please join us to raise awareness for how 1.5+ million Americans suffering from #RA and their loved one’s cope with pain every day. See resources at: bit.ly/2Wz6KM4 bit.ly/3mEZYQf
1
5
Our Director of Research, Yaakov Levine PhD will be at CCR-E to discuss the ongoing RESET-RA study. Please stop by poster in Coral B Ballroom on 8/12 to say hello and learn more about the study using vagus nerve stimulation to treat #RA. #TheSetPointAdvantage #CCREast #CCR21
2
5
We are looking forward to discussing SetPoint’s recent developments at the LifeSci Partners Private Company Summer Symposium. CEO Murthy Simhambhatla will present virtually July 22nd from 3:30 – 3:55 pm ET. #TheSetPointAdvantage #LifeSci #bioelectronicmedicine
5
6
Thank you, @NANS_ION, for the opportunity to present SetPoint's bioelectronic medicine platform for patients with #RA! We enjoyed the discussions to bolster advancement in #neuromodulation at the #NANSMidYear meeting. #NANS2021 #TheSetPointAdvantage
1
7
With vaccinations and easing of Covid restrictions, the #SetPoint team celebrated the reopening of our offices with a company picnic. It was a blast reconnecting in-person again! Thank you to our dedicated team for their perseverance in developing #bioelectronicmedicine.
4
#RA affects nearly 1.5 million Americans. Today, we take a moment to bring attention to this chronic disease, and raise awareness for this underserved population. #TheSetPointAdvantage #RAday
3
5
Learn more about the potential of vagus nerve stimulation as an alternate treatment option for RA in this recent @CreakyJoints article: bit.ly/33Ri44p #TheSetPointAdvantage
2
3
We are hiring for various clinical roles. Come join the team that is revolutionizing patient care with #bioelectronicmedicine. Learn more about current opportunities: bit.ly/2PYYvUo #TheSetPointAdvantage
1
2
We are excited to present our pilot rheumatoid arthritis study results at the upcoming annual @ACRheum Meeting in Atlanta this weekend! #ACR19 #TheSetPointAdvantage
1
1
3
SetPoint Medical is continuously inspired by @vagusnervegirl's story as we advance our therapy so more patients like Kelly can experience the potential benefits of #BioelectronicMedicine. Read more from the @TIME article here: bit.ly/2WOyF76 #TheSetPointAdvantage
1
1
7
SetPoint Medical #BioelectronicMedicine device's recent progress as a potential #RA treatment was featured as @GoHealio Rheumatology's cover story: bit.ly/2W04RE7
1
SetPoint Medical celebrated the end of a productive summer with a company picnic last week to recognize our stellar employees and their families. To us, diversity and talent are vital for our mission to pioneer bioelectronic medicine. #WorkHardPlayHard #TheSetPointAdvantage
Recent coverage by @MDDIonline on enrollment completion for the pilot study of our proprietary #bioelectronicmedicine device to treat drug refractory #rheumatoidarthritis mddionline.com/setpoint-stri…
1
6
New research strengthens the understanding of science behind #vagusnerve role in regulating inflammation related to cognitive function after injury & surgery corporate.dukehealth.org/new…
2
4
SetPoint Medical announces Murthy Simhambhatla as new President and CEO. We welcome his extensive healthcare industry leadership as we advance our proprietary #bioelectronicmedicine platform to treat patients with debilitating #autoimmune diseases. setpointmedical.com/setpoint…
4
5
.@SetPointMedi presents positive data from clinical study of #bioelectronicmedicine for #CrohnsDisease setpointmedical.com/setpoint…
2
4
.@SetPointMedi happy to announce new Senior Dir. Commercialization & Mkting for our #bioelectronicmedicine platform medtech.pharmaintelligence.i…
1
2
FDA #approves SetPoint Investigational Device Exemption - can begin #RA #pilottrial w/ proprietary #bioelectronicmedicine device setpointmedical.com/fda-appr…
4
6
Forging trail in #bioelectronicmedicine @PharmaVOICE: work to treat chronic #inflammatorydisease #RA #Crohns #MS holds promise of new treatment options for patients where traditional meds fail pharmavoice.com/article/2017…
3
2
Take a look @setpointmedi a leader in the #bioelectronicmedicine medtech area on @nature biopharma dealmakers biopharmadealmakers.nature.c…
2
2
#BioelectronicMedicine is changing drug treatment paradigm for patients says SetPoint co-founder Kevin Tracey beckershospitalreview.com/su…
In @PJOnline_News #bioelectronicmedicine to find new treatments for chronic diseases, incl. SetPoint Crohn's data pharmaceutical-journal.com/n…
1
1
SetPoint Crohn’s data highlighted @FierceBiotech with #bioelectronicmedicine as top med tech trend to watch in 2017 fiercebiotech.com/medical-de…
SetPoint's bioelectronic therapy attenuates RA disease severity and inhibits inflammatory cytokine production.
1
Vote for the Bioelectronic Medicine panel at SXSW to see SetPoint leadership speak about the future of the therapy.